Tag: Larimar
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...
NEW YORK, June 02, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Larimar Therapeutics, Inc....
Larimar Therapeutics Reports FDA Clinical Hold on CTI-1601 and Termination of...
BALA CYNWYD, Pa., May 25, 2021 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on...